Journals
Publish with us
Publishing partnerships
About us
Blog
International Journal of Hypertension
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
International Journal of Hypertension
/
2021
/
Article
/
Tab 4
/
Research Article
Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension
Table 4
The mean percentage of the active ingredient in AML/VAL suspension throughout 4-week period at room temperature.
Weak
% of remaining drug
AML
VAL
Initial
102.1
106.2
Week 1
101.8
105.3
Week 2
99.1
102.2
Week 3
98.3
101.9
Week 4
97.3
101.1